itNETZ: Integrative and Translational Network-based Cellular Signature Analyzer

itNETZ:基于集成和翻译网络的细胞特征分析仪

基本信息

  • 批准号:
    8231114
  • 负责人:
  • 金额:
    $ 38.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-24 至 2013-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There is an urgent need to develop systematic platforms to address the challenges and opportunities brought forth by the fast progresses of the Library of Integrated Network-Based Cellular Signatures (LINCS) program. The LINCS program performs cross-cutting high-throughput assays and develops integrative computational analysis of informative molecular activity and cellular feature signatures generated in response to a variety of perturbing agents and drug candidates. The primary goal of the proposed study is to address the needs by developing a signature-oriented software platform, the Integrative and Translational Network-based Cellular Signature Analyzer (itNETZ). The working flow of the system is: 1) to identify disease- and drug-specific molecular and cellular features, 2) to reveal the mechanismistic associations between components of such features and delineate them as signaling and regulating networks, 3) to present the dynamics of such networks by mathematical models, 4) to construct network-based molecular and cellular signatures, 5) to discover common signatures and networks across cell lines and diseases, 6) to establish and maintain a public resource of the increasing resultant knowledge of therapeutic responses, and 7) to facilitate the research community on querying signatures of interests, exploring correlations among signatures, and generating hypotheses. This system will enable the following functions: first, the basic analysis and discovery toolkits for processing cellular images, Luminex genomics data, transcriptome sequencing data, and for modeling phosphoproteins signaling pathway; and second, data integration and mining toolkits for mapping genomics and proteomics to cellular phenotypes, for core pathway signature identification on cell lines treated by different inhibitors and drug-induced pathway signature alterations, and for constructing drug kinome landscapes. The itNETZ system comprises pipelines that load input, analyze images, process genomics and proteomics data, export outputs into a relational database, integrate and mine the data, and generate network-based cellular signatures of interest. XML-based protocols will be used for data exchanging. PUBLIC HEALTH RELEVANCE: This project will be a substantial contribution to the public health by understanding the mechanism of drugs, and network signature under different treatment conditions. More importantly, the completion of this project will help to answer some critical questions related to drug target signatures. Such understanding will in turn advance our knowledge in tumor biology and open up the possibility of novel treatments in the future.
描述(由申请人提供):迫切需要开发系统平台,以应对集成网络蜂窝签名库(LINCS)计划快速发展所带来的挑战和机遇。LINCS程序进行交叉高通量检测,并开发信息分子活性和细胞特征签名的综合计算分析,以响应各种干扰剂和候选药物。 拟议的研究的主要目标是通过开发一个面向签名的软件平台,集成和翻译的基于网络的蜂窝签名分析仪(itNETZ),以满足需求。 系统的工作流程为:1)识别疾病和药物特异性分子和细胞特征,2)揭示这些特征的组分之间的机制关联,并将它们描绘为信号传导和调节网络,3)通过数学模型呈现这些网络的动力学,4)构建基于网络的分子和细胞特征,5)发现细胞系和疾病之间的共同特征和网络,6)建立和维护治疗反应的日益增长的结果知识的公共资源,以及7)促进研究团体查询感兴趣的特征,探索特征之间的相关性,并产生假设。 该系统将实现以下功能:第一,用于处理细胞图像、Luminex基因组学数据、转录组测序数据以及用于对磷蛋白信号通路进行建模的基本分析和发现工具包;第二,用于将基因组学和蛋白质组学映射到细胞表型的数据集成和挖掘工具包,用于在由不同抑制剂处理的细胞系上鉴定核心途径签名和药物诱导的途径签名改变,以及用于构建药物激酶组景观。itNETZ系统包括加载输入、分析图像、处理基因组学和蛋白质组学数据、将输出导出到关系数据库、整合和挖掘数据以及生成感兴趣的基于网络的细胞签名的管道。基于XML的协议将用于数据交换。 公共卫生相关性:本项目将通过了解药物的作用机制,以及不同治疗条件下的网络签名,为公共卫生做出实质性贡献。更重要的是,该项目的完成将有助于回答与药物靶向特征相关的一些关键问题。这样的理解将反过来推进我们在肿瘤生物学方面的知识,并为未来的新治疗开辟可能性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xiaobo Zhou其他文献

Xiaobo Zhou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xiaobo Zhou', 18)}}的其他基金

Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
使用单细胞测序数据 (scDEC) 对块状肿瘤中不同细胞类型进行去卷积的多尺度分辨率和深度网络方法
  • 批准号:
    10685960
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
使用单细胞测序数据 (scDEC) 对块状肿瘤中不同细胞类型进行去卷积的多尺度分辨率和深度网络方法
  • 批准号:
    9803214
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
使用单细胞测序数据 (scDEC) 对块状肿瘤中不同细胞类型进行去卷积的多尺度分辨率和深度网络方法
  • 批准号:
    10226049
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
使用单细胞测序数据 (scDEC) 对块状肿瘤中不同细胞类型进行去卷积的多尺度分辨率和深度网络方法
  • 批准号:
    10458544
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
Multiscale Resolution and Deep Network Approaches for Deconvolving Different Cell Types in Bulk Tumor using Single-cell Sequencing Data (scDEC)
使用单细胞测序数据 (scDEC) 对块状肿瘤中不同细胞类型进行去卷积的多尺度分辨率和深度网络方法
  • 批准号:
    10117064
  • 财政年份:
    2019
  • 资助金额:
    $ 38.88万
  • 项目类别:
A Novel Informatics System For Craniosynostosis Surgery
颅缝早闭手术的新型信息学系统
  • 批准号:
    10286746
  • 财政年份:
    2017
  • 资助金额:
    $ 38.88万
  • 项目类别:
A Novel Informatics System for Craniosynostosis Surgery
颅缝早闭手术的新型信息学系统
  • 批准号:
    10199743
  • 财政年份:
    2017
  • 资助金额:
    $ 38.88万
  • 项目类别:
A Novel Informatics System for Craniosynostosis Surgery
颅缝早闭手术的新型信息学系统
  • 批准号:
    9360750
  • 财政年份:
    2017
  • 资助金额:
    $ 38.88万
  • 项目类别:
Integrative approach to studying LncRNA functions
研究 LncRNA 功能的综合方法
  • 批准号:
    9751927
  • 财政年份:
    2017
  • 资助金额:
    $ 38.88万
  • 项目类别:
Integrative approach to studying LncRNA functions
研究 LncRNA 功能的综合方法
  • 批准号:
    10119971
  • 财政年份:
    2017
  • 资助金额:
    $ 38.88万
  • 项目类别:

相似海外基金

Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
  • 批准号:
    23K06731
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
  • 批准号:
    23K06616
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
  • 批准号:
    EP/Y024591/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10672364
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
  • 批准号:
    10383462
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
  • 批准号:
    10483063
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10546865
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
  • 批准号:
    2752732
  • 财政年份:
    2022
  • 资助金额:
    $ 38.88万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了